PAR paradigm biopharmaceuticals limited..
Add to My Watchlist 1.15% ! 43.0¢

FDA delay for ph 3 trial approval, page-4

  1. RTheo
    474 Posts.
    lightbulb Created with Sketch. 107
    clock Created with Sketch.
    03/09/24
    16:25
    Post #: 75509720
    It was 'imminent' five weeks ago according to Paul Rennie. One wonders what difficulties PAR has created for the FDA.

    PAR Price at posting: 23.5¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

VMM Colossus PFS Unlocks World-Class Project Economics and Positions Viridis for Global Leadership
right-arrow Created with Sketch.
NEWS Gold and Copper Targets Identified by Koonenberry at Prince of Wales Project
right-arrow Created with Sketch.
NEWS Copper and Base Metals Targets Confirmed at Minbrie with Drilling Ahead
right-arrow Created with Sketch.
NUZ Positive FDA feedback on NUZ-001 strategy to lift clinical hold
right-arrow Created with Sketch.
NEWS Anson Adds 100 Strategic Claims to Green River Lithium Project
right-arrow Created with Sketch.
NEWS Modelling Confirms Exceptional Heat Sink Performance for VHD Technology
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
43.0¢ 		Change
-0.005(1.15%) 		Mkt cap ! $170.8M
Open High Low Value Volume
43.5¢ 43.5¢ 40.5¢ $532.2K 1.265M

Buyers (Bids)

No. Vol. Price($)
1 4500 41.5¢
 

Sellers (Offers)

Price($) Vol. No.
43.0¢ 9422 3
View Market Depth
Last trade - 16.10pm 10/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.